11.9 USD
-0.29 (-2.38%)
11.9 USD
0 (0%)
IART gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. IART has a medium profitability rating, but doesn't score so well on its financial health evaluation. IART has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- In the past year IART was profitable.
- In the past year IART had a positive cash flow from operations.
- Of the past 5 years IART 4 years were profitable.
- IART had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- IART has a Return On Assets (-13.58%) which is comparable to the rest of the industry.
- Looking at the Return On Equity, with a value of -47.74%, IART is in line with its industry, outperforming 51.61% of the companies in the same industry.
- IART has a Return On Invested Capital of 4.27%. This is in the better half of the industry: IART outperforms 74.73% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for IART is below the industry average of 8.84%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.58% | ||
| ROE | -47.74% | ||
| ROIC | 4.27% |
ROA(3y)2.09%
ROA(5y)2.89%
ROE(3y)4.61%
ROE(5y)6.54%
ROIC(3y)6.1%
ROIC(5y)6.15%
1.3 Margins
- IART's Operating Margin of 10.22% is fine compared to the rest of the industry. IART outperforms 79.03% of its industry peers.
- In the last couple of years the Operating Margin of IART has declined.
- The Gross Margin of IART (57.21%) is comparable to the rest of the industry.
- IART's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.22% | ||
| PM (TTM) | N/A | ||
| GM | 57.21% |
OM growth 3Y-14.31%
OM growth 5Y-7.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.19%
GM growth 5Y-1.66%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IART is destroying value.
- Compared to 1 year ago, IART has less shares outstanding
- The number of shares outstanding for IART has been reduced compared to 5 years ago.
- The debt/assets ratio for IART is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.24, we must say that IART is in the distress zone and has some risk of bankruptcy.
- IART's Altman-Z score of 1.24 is in line compared to the rest of the industry. IART outperforms 52.69% of its industry peers.
- IART has a Debt/Equity ratio of 1.73. This is a high value indicating a heavy dependency on external financing.
- IART's Debt to Equity ratio of 1.73 is on the low side compared to the rest of the industry. IART is outperformed by 80.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.73 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.24 |
ROIC/WACC0.55
WACC7.78%
2.3 Liquidity
- IART has a Current Ratio of 3.14. This indicates that IART is financially healthy and has no problem in meeting its short term obligations.
- IART has a Current ratio (3.14) which is in line with its industry peers.
- A Quick Ratio of 1.80 indicates that IART should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.80, IART is in line with its industry, outperforming 48.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.14 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
- IART shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.44%.
- The Earnings Per Share has been decreasing by -1.35% on average over the past years.
- The Revenue has been growing slightly by 4.99% in the past year.
- Measured over the past years, IART shows a small growth in Revenue. The Revenue has been growing by 1.20% on average per year.
EPS 1Y (TTM)-4.44%
EPS 3Y-6.97%
EPS 5Y-1.35%
EPS Q2Q%31.71%
Revenue 1Y (TTM)4.99%
Revenue growth 3Y1.45%
Revenue growth 5Y1.2%
Sales Q2Q%5.57%
3.2 Future
- IART is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.68% yearly.
- Based on estimates for the next years, IART will show a small growth in Revenue. The Revenue will grow by 2.39% on average per year.
EPS Next Y-12.33%
EPS Next 2Y-3.22%
EPS Next 3Y1.53%
EPS Next 5Y2.68%
Revenue Next Year1.09%
Revenue Next 2Y1.9%
Revenue Next 3Y2.45%
Revenue Next 5Y2.39%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 5.02, the valuation of IART can be described as very cheap.
- Compared to the rest of the industry, the Price/Earnings ratio of IART indicates a rather cheap valuation: IART is cheaper than 98.39% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.21, IART is valued rather cheaply.
- Based on the Price/Forward Earnings ratio of 4.96, the valuation of IART can be described as very cheap.
- Based on the Price/Forward Earnings ratio, IART is valued cheaply inside the industry as 99.46% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 25.98. IART is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.02 | ||
| Fwd PE | 4.96 |
4.2 Price Multiples
- IART's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IART is cheaper than 95.70% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.7 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.22%
EPS Next 3Y1.53%
5. Dividend
5.1 Amount
- No dividends for IART!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
INTEGRA LIFESCIENCES HOLDING / IART FAQ
Can you provide the ChartMill fundamental rating for INTEGRA LIFESCIENCES HOLDING?
ChartMill assigns a fundamental rating of 4 / 10 to IART.
What is the valuation status for IART stock?
ChartMill assigns a valuation rating of 6 / 10 to INTEGRA LIFESCIENCES HOLDING (IART). This can be considered as Fairly Valued.
What is the profitability of IART stock?
INTEGRA LIFESCIENCES HOLDING (IART) has a profitability rating of 4 / 10.
What is the financial health of INTEGRA LIFESCIENCES HOLDING (IART) stock?
The financial health rating of INTEGRA LIFESCIENCES HOLDING (IART) is 3 / 10.